AUG 10, 2021 7:00 AM PDT

A Tapeworm Drug as a COVID Antiviral?

WRITTEN BY: Tara Fernandez

A study by researchers at the Scripps Research Institute looking into potential COVID-19 medications has revealed a surprising lead candidate: a drug currently used to treat tapeworm infections. The compound was shown to not only dampen inflammation but block the proliferation of SARS-CoV-2, making it a promising potential therapeutic to treat severe cases of COVID-19.

Tapeworms are flat, segmented parasites that live in the intestines of animals. These worms can be transmitted to humans by eating undercooked meat but are easily treated with a class of small molecules called salicylanilides.

Interestingly, salicylanilides have also been known to have potent antiviral effects, which led researchers to hypothesize that they may repurpose them to treat COVID-19. The problem, however, is that salicylanilides are typically restricted to treating gut-related infections, and, to make matters worse, high doses of the drugs are known to be toxic.

To overcome these barriers, a team of scientists led by Kim Janda screened a panel of 60 modified salicylanilide molecules in rodents before identifying one compound with a low toxicity profile that was readily absorbed into the bloodstream from the digestive tract.

Janda and colleagues found two critical features of this compound that make it an attractive option for treating COVID-19—it disrupts the mechanism by which the coronavirus deposits its genetic material into human cells, and it calms inflammation by reducing levels of an inflammatory cytokine called interleukin-6.

“The combination of anti-SARS-CoV-2 activity, cytokine inhibitory activity, and a previously established favorable pharmacokinetic profile for the lead salicylanilide render salicylanilides in general as promising therapeutics for COVID-19,” wrote the authors.

 



Source: ACS Infectious Diseases.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 10, 2021
Immunology
An Immune Molecule Helps Create 'Good' Fat
AUG 10, 2021
An Immune Molecule Helps Create 'Good' Fat
Not all fat is ‘bad’—there’s white fat that builds up when excess calories are consumed. But, th ...
AUG 27, 2021
Health & Medicine
Blood Group and COVID-19 Susceptibility- An Ongoing Debate
AUG 27, 2021
Blood Group and COVID-19 Susceptibility- An Ongoing Debate
Since their discovery, there has been an interest in how ABO blood groups and infectious diseases may be related. In add ...
AUG 31, 2021
Health & Medicine
People Who Have Had SARS-CoV-2 Infection Have Longer-Lasting Immunity Than Those Who Were Vaccinated Only
AUG 31, 2021
People Who Have Had SARS-CoV-2 Infection Have Longer-Lasting Immunity Than Those Who Were Vaccinated Only
Consider yourself among the luckiest if you made a full recovery from infection with SARS-CoV-2, especially if you were ...
SEP 07, 2021
Immunology
Designer Cells for Treating Arthritis Are Activated by Inflammation
SEP 07, 2021
Designer Cells for Treating Arthritis Are Activated by Inflammation
Scientists have developed a new cell therapy for arthritis that becomes activated in the presence of inflammation. When ...
SEP 13, 2021
Health & Medicine
How Farming Shaped the Immune System
SEP 13, 2021
How Farming Shaped the Immune System
In today's society, a rural upbringing is associated with a healthier immune system less prone to allergies and auto ...
SEP 27, 2021
Cell & Molecular Biology
Newly Identified Cell Type is Linked to Chronic Skin Disorders
SEP 27, 2021
Newly Identified Cell Type is Linked to Chronic Skin Disorders
The chronic skin disease atopic dermatitis (AD) is estimated to affect about 15 percent of children worldwide, and for s ...
Loading Comments...